Monday, 12th October 9th Venoms to Drugs 2026

• Mapping the Pharmacophore of a Venom-Derived Peptide TMEM233 ligand - Irina Vetter
• Properties of the mCherry fluorescence protein-tagged scorpion toxin Vm24 with picomolar affinity for the Kv1.3 K⁺ channel - Gyorgy Panyi
• Discovering and optimising venom-derived ligands for ASIC1 channels - Ben Cristofori-Armstrong
• α- and Ω-Neurotoxins Reveal Distinct Principles of Nicotinic Acetylcholine Receptor Subtype and Interface Recognition - Manjunatha Kini

• Venom Variation as Opportunity and Challenge: Drug Discovery and Snakebite Treatment - Kartik Sunagar
• Genomic investigation of host / snake venom interactions - Mathew MS Samuel
• Saxiphilin functions as a ‘toxin sponge’ protein that counteracts the effects of saxitoxin poisoning - Samantha A Nixon
• ‘Toxin sponge’ proteins provide defense against a toxic environment - Daniel L Minor

• Decoding what evolution built and designing what it never did: Generative AI unlocks protein sequencing and protein design - Timothy Jenkins
• From ant venom to antibiofilm drug leads for treating gut disorders - Bernhard Jandl
• Chemical synthesis of anticoagulant sulfoproteins as novel anticoagulants - Emma Watson
• Total Chemical Synthesis of HCRG21, a Venom-derived Inhibitor of TRPV1 with Therapeutic Potential - Paul Harris

18:00 - 18:30 Drinks at Sand court

18:30 - 20:30 BBQ Dinner at Sand bar